News
The Namita Thapar led Emcure Pharma's shares were locked in the upper circuit increasing 10 per cent to hit Rs 1288.65 after posting a rise in its quarter four ended March 2025 net profit.
Namita Thapar shares a poem about leadership. The poem uses trees as metaphors. It shows the value of old and new ideas. The ...
Emcure Pharmaceuticals shares surged 10% to ₹1,288.65, driven by strong Q4FY25 results with a 64% profit increase. The ...
Juggling boardrooms, brands, and babies isn’t easy, but these dynamic women from Shark Tank India have spoken candidly about ...
Namita Thapar invests Rs 3 crore in The Bear House on Shark Tank India The Bear House secures Rs 3 crore investment on Shark Tank India to fuel expansion and growth. Namita Thapar says this ...
These hints might have been enough for you to understand that we are talking about none other than Namita Thapar. Namita is a famous businesswoman and has also become a TV celebrity with her ...
Namita Thapar, Shark Tank India judge and Emcure Pharmaceuticals Executive Director, reflects on work-life balance and parenting challenges prompted by Netflix's Adolescence series. She stresses ...
Shark Tank ' judge Namita Thapar, on Tuesday, reacted to the social media trolling for not investing in Vineeta Singh's competitor brand. Taking to Twitter, Namita wrote, "Being a shark doesn't ...
Packaged water brand Aquapeya, funded by Shark Tank’s Namita Thapar and Ritesh Agarwal, has been ordered by the Bombay High Court to halt operations after Bisleri International accused it of ...
The Jaipur-based startup, which earlier grabbed headlines for securing a deal at an INR 100 crore valuation on Shark Tank India from Namita Thapar, plans to utilise the fresh capital to expand its ...
Out of the five judges present, only Thapar offered to fund Girgit. Other sharks rejected the offer as they saw issues with scaling the business. The founder accepted Thapar’s offer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results